Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Dematomyositis

Keck School of Medicine of USC

B. Ngo

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

68 y/o Asian Female With 4 Months of Recurrent Urticaria: Diagnosis …

RheumNow

P. Teh

Bullous Pemphigoid Updates (2024)

NYU Langone

P. Adotama

Dermatomyositis Overview

Masterclasses in Dermatology

J. Merola

Pulmonary Involvement in Rheumatic Diseases: A Review

Brigham and Women's Hospital

P. Dellaripa

Update on the Diagnosis and Treatment of FMF (Familial Mediterranean…

Black Sea Rheumatology, 2023

A. Gül

IgG4-Related Disease: An Introduction

Zachary Wallace

ATS 2024 Insights: Management Decisions After Early Detection of CTD…

Insights from 2024 ATS Annual Meeting

S. Matson

Clinical Use and Drug Interactions of Common Supplements in Dermatol…

University of Miami

E. Hadeler

IL-6 Inhibitors, Frailty and Polymyalgia Rheumatica

RheumNow

S. Sattui

The Best of Both Worlds: Using Integrative Approaches in Atopic Derm…

The Skin Real

M. Mina, P. Lio

Is It Your Thyroid?

The Skin Real

M. Mina, D. Gibbs

AAD 2024 Insights: Clinical Pearls in Autoimmune Connective Tissue D…

AAD 2024

S. Elman

Connective Tissue Disease Serologies!

Masterclasses in Dermatology

J. Merola

Differentiating Serological Markers in Autoimmune Disorders

Keck School of Medicine of USC

J. Jun

Connective Tissue Disease-associated Interstitial Lung Disease (CTD-…

Pulmonology Read Aloud

A. Aneja Arora

2021 Rheumatology Year in Review: New FDA Approvals and Indications,…

RheumNow

J. Cush

Synovium: What's Important to Know

Cleveland Clinic Rheumatology and Immunology Series

A. Brown